Koers Stemcell Holdings, Inc. Other OTC
Aandelen
STMM
US85858N2027
Farmaceutische producten
Omzet 2016 | 3,34 mln. 3,11 mln. | Omzet 2017 | 6,18 mln. 5,76 mln. | Marktkapitalisatie | 1,64 mln. 1,53 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2016 | 1 mln. 932K | Nettowinst (verlies) 2017 | 2 mln. 1,86 mln. | EV/omzet 2016 * | - |
Nettoliquiditeiten 2016 * | - 0 | Nettoliquiditeiten 2017 * | - 0 | EV/omzet 2017 * | - |
K/w-verhouding 2016 * |
-
| K/w-verhouding 2017 * |
-
| Werknemers | - |
Dividendrendement 2016 * |
-
| Dividendrendement 2017 * |
-
| Vrij verhandelbaar | 99% |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+2,08% | 95,18 mld. | |
-0,13% | 37,55 mld. | |
-10,70% | 33,75 mld. | |
+77,76% | 28,2 mld. | |
-15,10% | 15,63 mld. | |
-3,34% | 13,63 mld. | |
-12,76% | 11,5 mld. | |
+181,73% | 10,81 mld. | |
-53,92% | 9,23 mld. |